Corrigendum to “Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatment” [Biomed. Pharmacother. 183 (2025) 117829] - 03/09/26

Alexander G. Grønning ^{a, b,} 1

  These authors contributed equally to this work.

, Sebastian E. Vonhof ^c, 1

  These authors contributed equally to this work.

, Mahmoud Elbatreek ^{d, e}, Anna Hamker ^c, Rebecca D. Szepanowski ^c, Svenja C. Erkelenz ^c, Friederike Langhauser ^c, Javier Egea ^f, Manuela G. Lopez ^g, Jan Baumbach ^{b, h}, Christoph Kleinschnitz ^c, Ana I. Casas ^{c, e, ⁎}

^a Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copengagen 2200, Denmark 

^b Department of Mathematics and Computer Science, University of Southern Denmark, Odense 5230, Denmark 

^c Department of Neurology and Center for Translational Neuro, and Behavioural Sciences (C-TNBS), Department of Neurology, University Hospital Essen, Essen 45147, Germany 

^d Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt 

^e Department of Pharmacology & Personalised Medicine, MeHNS, Faculty of Health, Medicine & Life Science, Maastricht University, Maastricht, ER 6229, the Netherlands 

^f Instituto de Investigación Sanitaria, Servicio de Farmacología Clínica, Hospital Universitario de la Princesa, Madrid 28006, Spain 

^g Instituto de I+D del Medicamento Teófilo Hernando (ITH), Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid 28029, Spain 

^h Institute for Computational Systems Biology, University of Hamburg, Hamburg 22761, Germany 

^⁎ Correspondence to: Department of Neurology, University Hospital, Essen 45147, Germany. Department of Neurology, University Hospital Essen 45147 Germany

Le texte complet de cet article est disponible en PDF.